Why CRISPR Therapeutics AG Stock Is Rising Today – Motley Fool
Nasdaq |
Why CRISPR Therapeutics AG Stock Is Rising Today
Motley Fool Specifically, the company announced a underwritten public offering of 5,000,000 of its common shares at a public offering price of $22.75 per share before the start of today's session. Under normal circumstances, a secondary offering that equates to a … CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) Stock CRISPR Therapeutics Announces Proposed Public Offering of Common Shares |
